
Genavinta is an AI-powered clinical genomics company dedicated to revolutionizing cancer care. Their platform processes vast genetic datasets to deliver actionable insights, enabling faster and more precise treatment decisions for patients. Genavinta addresses the critical gap in genomic diversity by actively analyzing data from diverse populations, aiming to ensure treatments are effective for everyone. The company combines pathology, medical history, and treatment outcomes for a holistic patient view, offering real-time updates to disease models. Their mission is to democratize genetic medicine by building a diverse genetic database and making its insights accessible globally, starting with cancer care. They are headquartered in Germany and India.

Genavinta is an AI-powered clinical genomics company dedicated to revolutionizing cancer care. Their platform processes vast genetic datasets to deliver actionable insights, enabling faster and more precise treatment decisions for patients. Genavinta addresses the critical gap in genomic diversity by actively analyzing data from diverse populations, aiming to ensure treatments are effective for everyone. The company combines pathology, medical history, and treatment outcomes for a holistic patient view, offering real-time updates to disease models. Their mission is to democratize genetic medicine by building a diverse genetic database and making its insights accessible globally, starting with cancer care. They are headquartered in Germany and India.